Your browser doesn't support javascript.
loading
TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation.
Dao, Tram N; Utturkar, Sagar; Atallah Lanman, Nadia; Matosevic, Sandro.
Afiliação
  • Dao TN; Department of Industrial and Physical Pharmacy, Purdue University, West Lafayette, IN 47907, USA.
  • Utturkar S; Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.
  • Atallah Lanman N; Center for Cancer Research, Purdue University, West Lafayette, IN 47907, USA.
  • Matosevic S; Department of Comparative Pathobiology, Purdue University, West Lafayette, IN 47907, USA.
Cancers (Basel) ; 12(9)2020 Aug 26.
Article em En | MEDLINE | ID: mdl-32858904
ABSTRACT
Among natural killer (NK) cell receptors, the T-cell immunoglobulin and mucin-containing domain (TIM-3) has been associated with both inhibitory and activating functions, depending on context and activation pathway. Ex vivo and in vitro, expression of TIM-3 is inducible and depends on activation stimulus. Here, we report that TIM-3 expression can be downregulated on NK cells under specific conditions. When NK cells are exposed to cancer targets, they synergize with stimulation conditions to induce a substantial decrease in TIM-3 expression on their surface. We found that such downregulation occurs following prior NK activation. Downregulated TIM-3 expression correlated to lower cytotoxicity and lower interferon gamma (IFN-γ) expression, fueling the notion that TIM-3 might function as a benchmark for human NK cell dysfunction.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article